Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Healthcare Industry News Leo Cancer Care explores TibaRay linacs to power development of Grace photon therapy platform Leo Cancer Care is evaluating TibaRay linacs for its Grace photon therapy platform, signaling a new era in upright and FLASH radiotherapy innovation. bySoujanya RaviOctober 3, 2025